TrialsgrambetaRCTs are beautiful

SYGMA 2

2018

Symbicort Given As Needed in Mild Asthma 2

In 4,215 patients with mild asthma, PRN budesonide-formoterol was non-inferior for severe exacerbations compared with daily maintenance budesonide plus PRN terbutaline.

Result

Efficacy: Annual rate of severe exacerbationsRR 0.97

Below 1 favours PRN budesonide-formoterol, above 1 favours daily maintenance budesonide plus PRN terbutaline.

Also reported: (non-inferior) with ~25% of the ICS dose.

Original publication
Subtopic
PRN ICS-formoterol
Design
Multicentre RCT
Relevance
Important: one of several pillars.
Source
Bateman ED, et al. N Engl J Med. 2018;378(20):1877-1887.doi 10.1056/NEJMoa1715275

Discussion & critique

Cemented PRN ICS-formoterol as an alternative to daily maintenance ICS in mild asthma.